## LOW: Lowe's Companies, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 2.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($237.18)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Gradient Investments LLC Grows Stock Holdings in Lowe's Companies, Inc. $LOW**
- Source: MarketBeat | 20251217T092054 | Bullish | Relevance: 100%
- Gradient Investments LLC increased its stake in Lowe's Companies, Inc. by 7.2% in the third quarter, bringing its total holdings to 146,984 shares valued at $36.94 million. The home improvement retailer exceeded Q3 EPS estimates with $3.06 per share and reported $20.81 billion in revenue, also declaring a quarterly dividend of $1.20. Analysts currently assign Lowe's a "Moderate Buy" rating with a consensus target price of $275.92.

**2. Fragasso Financial Advisors Inc Decreases Holdings in Lowe's Companies, Inc. $LOW**
- Source: MarketBeat | 20251217T090810 | Neutral | Relevance: 100%
- Fragasso Financial Advisors Inc significantly reduced its stake in Lowe's Companies, Inc. (NYSE:LOW) by 29.8% in Q3, selling 4,765 shares and holding 11,200 shares valued at $2.759 million. Despite this, analyst sentiment remains a "Moderate Buy" with a consensus price target of $275.92, though some firms have slightly trimmed their price targets. Lowe's reported strong Q3 earnings, beating EPS estimates and providing optimistic FY2025 guidance, alongside declaring a $1.20 quarterly dividend.

**3. Caxton Associates LLP Grows Holdings in Lowe's Companies, Inc. $LOW**
- Source: MarketBeat | 20251216T092706 | Somewhat-Bullish | Relevance: 100%
- Caxton Associates LLP significantly increased its stake in Lowe's Companies, Inc. by 149.8% in Q2, acquiring 4,402 additional shares to own a total of 7,341 shares worth $1.629 million. Lowe's recently surpassed Q3 EPS estimates, reporting $3.06 per share against a $2.97 consensus, with revenue up 3.2% year-over-year to $20.81 billion. The company maintains a "Moderate Buy" consensus rating with an average target price of $275.92 and offers a quarterly dividend of $1.20, equating to a 1.9% annualized yield.

**4. Shorepoint Capital Partners LLC Takes $6.45 Million Position in Lowe's Companies, Inc. $LOW**
- Source: MarketBeat | 20251216T124338 | Somewhat-Bullish | Relevance: 99%
- Shorepoint Capital Partners LLC has acquired a new stake of 25,672 shares in Lowe's Companies, Inc. (NYSE:LOW) valued at approximately $6.45 million, making it their 26th largest position. This comes as Lowe's beat Q3 EPS estimates and declared a quarterly dividend of $1.20. Analysts maintain a "Moderate Buy" rating for Lowe's with an average price target of $275.92.

**5. Jim Cramer Prefers Home Depot Over Builders FirstSource (BLDR)**
- Source: Insider Monkey | 20251217T123900 | Somewhat-Bullish | Relevance: 64%
- Jim Cramer favors Home Depot and Lowe's over Builders FirstSource (BLDR) due to the challenging housing market, despite acknowledging BLDR's potential for significant growth. He stated his Charitable Trust bought Home Depot to reduce risk while still being involved in the housing sector. Cramer also noted that Builders FirstSource's performance is tied to a strong housing market, hinting at potential falling mortgage rates if the company does well.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 9)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Oppenheimer | $315 | $320 | -2% |
| 2025-12-01 | Stifel | $250 | $230 | +9% |
| 2025-11-20 | UBS | $316 | $325 | -3% |
| 2025-11-20 | JP Morgan | $300 | $275 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Oppenheimer | main | Outperform |
| 2025-12-01 | Stifel | main | Hold |
| 2025-11-20 | UBS | main | Buy |
| 2025-11-20 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($0.41M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 13.4% (+138.6%)
- Vanguard Group Inc: 9.9% (+0.6%)
- Blackrock Inc.: 7.0% (-0.3%)
- FMR, LLC: 4.6% (-3.7%)
- State Street Corpora: 4.5% (+0.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 4 raises (avg +6%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.68 signals overvaluation risk, limited margin of safety. Forward P/E 19.0x stretched relative to 6% growth. Quality metrics strong (ROA 13%). Analyst sentiment negative (9 target cuts vs 4 raises). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $139.0B |
| Beta | 0.96 |
| 52W Range | $206.39 - $274.98 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.68 |
| Forward P/E | 19.0 |
| Current P/E | 20.2 |
| YoY Growth | 6.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 1.6% (minimal 5-day change). Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.62% (CS: 60) | Neutral |
| RSI_14 | 57.4 | Neutral |
| MACD Histogram | 0.47 | Bullish |
| vs SMA20 | 1.018x | Above |
| vs SMA50 | 1.035x | Above |
| vs SMA200 | 1.051x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $247.72
- **Stop Loss:** $237.18 (4.3% risk)
- **Target:** $258.26 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 108
- **Position Value:** $26,753.76
- **Portfolio %:** 26.75%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-25 (Est: $1.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.95 | $3.06 | +3.6% |
| 2025Q3 | $4.24 | $4.33 | +2.2% |
| 2025Q2 | $2.88 | $2.92 | +1.4% |
| 2025Q1 | $1.84 | $1.93 | +4.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*